AminoVita
Body Composition Protocol — 3-Compound Research Bundle
99%+ Purity
Guaranteed
Free
Shipping
Full COA
Included
GLP-3R 20mg
SLU-PP-322 5mg
Berberine
Berberine 60ct
Bundle Contents
Triple receptor agonist engaging GLP-1, GIP, and glucagon pathways simultaneously. Preclinical and early clinical data demonstrate significant incretin signaling modulation in research models.
ERRα agonist classified as an exercise-mimetic compound. Published literature indicates upregulation of metabolic gene expression profiles associated with endurance-type adaptations in murine subjects.
Berberine
60ct
Naturally derived isoquinoline alkaloid with well-documented AMPK pathway activation. Extensive in vitro and in vivo research supports its role in cellular energy-sensing and metabolic homeostasis regulation.
Purchased separately
$149.97
Bundle price
$124.99
Rationale
Contemporary metabolic research increasingly emphasizes the limitations of single-target interventions. This protocol addresses body composition through three distinct yet complementary mechanistic axes, each supported by a growing body of peer-reviewed literature.
Retatrutide engages the GLP-1, GIP, and glucagon receptor systems concurrently. Published trial data indicate significant modulation of appetite-regulatory and glucoregulatory cascades, representing a triple-agonist approach to incretin pathway research.
SLU-PP-322 selectively activates estrogen-related receptor alpha (ERRα), a transcription factor governing mitochondrial biogenesis and oxidative metabolism. Preclinical studies demonstrate upregulation of exercise-associated gene networks independent of physical activity.
Berberine activates adenosine monophosphate-activated protein kinase (AMPK), a master cellular energy sensor. Decades of published research describe its influence on glucose transporter expression, lipid metabolism, and mitochondrial function across multiple tissue types.
The convergence of incretin signaling, nuclear receptor activation, and AMPK-mediated energy sensing represents a multi-modal framework for metabolic research. Each compound operates through an independent mechanism, reducing pathway overlap while maximizing the breadth of metabolic targets under investigation. All compounds are supplied strictly for in vitro and in vivo research purposes.
Explore Further
